94 related articles for article (PubMed ID: 24615359)
1. Experimental selection of paromomycin and miltefosine resistance in intracellular amastigotes of Leishmania donovani and L. infantum.
Hendrickx S; Boulet G; Mondelaers A; Dujardin JC; Rijal S; Lachaud L; Cos P; Delputte P; Maes L
Parasitol Res; 2014 May; 113(5):1875-81. PubMed ID: 24615359
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome profiling identifies genes/pathways associated with experimental resistance to paromomycin in Leishmania donovani.
Verma A; Bhandari V; Deep DK; Sundar S; Dujardin JC; Singh R; Salotra P
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):370-377. PubMed ID: 29035735
[TBL] [Abstract][Full Text] [Related]
3. In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization.
Shaw CD; Lonchamp J; Downing T; Imamura H; Freeman TM; Cotton JA; Sanders M; Blackburn G; Dujardin JC; Rijal S; Khanal B; Illingworth CJ; Coombs GH; Carter KC
Mol Microbiol; 2016 Mar; 99(6):1134-48. PubMed ID: 26713880
[TBL] [Abstract][Full Text] [Related]
4. ABC transporter inhibition by beauvericin partially overcomes drug resistance in
Al Khoury C; Thoumi S; Tokajian S; Sinno A; Nemer G; El Beyrouthy M; Rahy K
Antimicrob Agents Chemother; 2024 May; 68(5):e0136823. PubMed ID: 38572959
[TBL] [Abstract][Full Text] [Related]
5. An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophages.
Siqueira-Neto JL; Moon S; Jang J; Yang G; Lee C; Moon HK; Chatelain E; Genovesio A; Cechetto J; Freitas-Junior LH
PLoS Negl Trop Dis; 2012; 6(6):e1671. PubMed ID: 22720099
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a Possible Synergistic Effect of Meglumine Antimoniate with Paromomycin, Miltefosine or Allopurinol on in Vitro Susceptibility of Leishmania tropica Resistant Isolate.
Rezaei Riabi T; Sharifi I; Miramin Mohammadi A; Khamesipour A; Hakimi Parizi M
Iran J Parasitol; 2013 Jul; 8(3):396-401. PubMed ID: 24454432
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Selection of Paromomycin and Miltefosine Resistance in Leishmania donovani and L. infantum in a Syrian Hamster Model.
Hendrickx S; Mondelaers A; Eberhardt E; Delputte P; Cos P; Maes L
Antimicrob Agents Chemother; 2015 Aug; 59(8):4714-8. PubMed ID: 26014955
[TBL] [Abstract][Full Text] [Related]
8. Intracellular amastigote replication may not be required for successful in vitro selection of miltefosine resistance in Leishmania infantum.
Hendrickx S; Mondelaers A; Eberhardt E; Lachaud L; Delputte P; Cos P; Maes L
Parasitol Res; 2015 Jul; 114(7):2561-5. PubMed ID: 25877390
[TBL] [Abstract][Full Text] [Related]
9. Fitness and Phenotypic Characterization of Miltefosine-Resistant Leishmania major.
Turner KG; Vacchina P; Robles-Murguia M; Wadsworth M; McDowell MA; Morales MA
PLoS Negl Trop Dis; 2015; 9(7):e0003948. PubMed ID: 26230675
[TBL] [Abstract][Full Text] [Related]
10. Leishmaniasis drug discovery: recent progress and challenges in assay development.
Zulfiqar B; Shelper TB; Avery VM
Drug Discov Today; 2017 Oct; 22(10):1516-1531. PubMed ID: 28647378
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between the promastigote back-transformation assay and miltefosine treatment outcome.
Hendrickx S; Eberhardt E; Mondelaers A; Rijal S; Bhattarai NR; Dujardin JC; Delputte P; Cos P; Maes L
J Antimicrob Chemother; 2015 Nov; 70(11):3023-6. PubMed ID: 26253089
[TBL] [Abstract][Full Text] [Related]
12. MAPK1 of Leishmania donovani modulates antimony susceptibility by downregulating P-glycoprotein efflux pumps.
Garg M; Goyal N
Antimicrob Agents Chemother; 2015 Jul; 59(7):3853-63. PubMed ID: 25870075
[TBL] [Abstract][Full Text] [Related]
13. Chemical proteomics versus leishmaniasis.
Ehrmann M; Kaschani F; Kaiser M
Chem Biol; 2015 Mar; 22(3):309-10. PubMed ID: 25794432
[TBL] [Abstract][Full Text] [Related]
14. In-silico analyses of natural products on leishmania enzyme targets.
Scotti L; Ishiki H; Mendonça Júnior FJ; Da Silva MS; Scotti MT
Mini Rev Med Chem; 2015; 15(3):253-69. PubMed ID: 25769973
[TBL] [Abstract][Full Text] [Related]
15. Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.
Berg M; García-Hernández R; Cuypers B; Vanaerschot M; Manzano JI; Poveda JA; Ferragut JA; Castanys S; Dujardin JC; Gamarro F
Antimicrob Agents Chemother; 2015 Apr; 59(4):2242-55. PubMed ID: 25645828
[TBL] [Abstract][Full Text] [Related]
16. Imipramine exploits histone deacetylase 11 to increase the IL-12/IL-10 ratio in macrophages infected with antimony-resistant Leishmania donovani and clears organ parasites in experimental infection.
Mukherjee S; Mukherjee B; Mukhopadhyay R; Naskar K; Sundar S; Dujardin JC; Roy S
J Immunol; 2014 Oct; 193(8):4083-94. PubMed ID: 25217162
[TBL] [Abstract][Full Text] [Related]
17. Antimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-β in early immune response.
Guha R; Das S; Ghosh J; Sundar S; Dujardin JC; Roy S
PLoS Negl Trop Dis; 2014 Jul; 8(7):e2995. PubMed ID: 25032977
[TBL] [Abstract][Full Text] [Related]
18. Cocrystals of a coumarin derivative: an efficient approach towards anti-leishmanial cocrystals against MIL-resistant Leishmania tropica.
Shahbaz M; Farooq S; Choudhary MI; Yousuf S
IUCrJ; 2024 Mar; 11(Pt 2):224-236. PubMed ID: 38427455
[TBL] [Abstract][Full Text] [Related]
19. Molecular Docking and Molecular Dynamics Simulations in Related to
Challapa-Mamani MR; Tomás-Alvarado E; Espinoza-Baigorria A; León-Figueroa DA; Sah R; Rodriguez-Morales AJ; Barboza JJ
Trop Med Infect Dis; 2023 Sep; 8(10):. PubMed ID: 37888585
[TBL] [Abstract][Full Text] [Related]
20. Long-term hematopoietic stem cells as a parasite niche during treatment failure in visceral leishmaniasis.
Dirkx L; Hendrickx S; Merlot M; Bulté D; Starick M; Elst J; Bafica A; Ebo DG; Maes L; Van Weyenbergh J; Caljon G
Commun Biol; 2022 Jun; 5(1):626. PubMed ID: 35752645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
